SIGN UP LOGIN    
IMGENEX INDIA PVT LTD
Country India
Tel +91 - 9937785307
URL www.imgenexindia.com

EXHIBITION    KOREA PHARM & BIO 2022

Booth No. 7B303
last updated on ( 2022-06-02 )

IMGENEX INDIA Pvt. Ltd., is one of the foremost biotechnology company in the Eastern region of India and was founded by Dr. Sujay Singh, Ph.D., in the year 2004 at Bhubaneswar. IMGENEX India has built a state-of-the-art R&D facility at the Infocity complex. The R&D unit of IMGENEX India was inaugurated in 2005 by Dr. APJ Abdul Kalam, the then Hon’ble President of India and is recognized by the Department of Scientific and Industrial Research (DSIR), Ministry of Science & Technology, Govt. of India. The R&D Unit of IMGENEX India possesses all the modern equipment for molecular biology, recombinant protein production, cell culture, antibody development and other downstream processes. The main goal of IMGENEX India is to provide affordable healthcare to less privileged patients. Over the years IMGENEX India has received several grants from the Department of Biotechnology (DBT) that includes SIBRI grant from to develop drugs for osteoporosis using nanotechnology based drug delivery.

more

EXHIBIT

COMPANY INTRODUCTION

IMGENEX INDIA Pvt. Ltd., is one of the foremost biotechnology company in the Eastern region of India and was founded by Dr. Sujay Singh, Ph.D., in the year 2004 at Bhubaneswar. IMGENEX India has built a state-of-the-art R&D facility at the Infocity complex. The R&D unit of IMGENEX India was inaugurated in 2005 by Dr. APJ Abdul Kalam, the then Hon’ble President of India and is recognized by the Department of Scientific and Industrial Research (DSIR), Ministry of Science & Technology, Govt. of India. The R&D Unit of IMGENEX India possesses all the modern equipment for molecular biology, recombinant protein production, cell culture, antibody development and other downstream processes. The main goal of IMGENEX India is to provide affordable healthcare to less privileged patients. Over the years IMGENEX India has received several grants from the Department of Biotechnology (DBT) that includes SIBRI grant from to develop drugs for osteoporosis using nanotechnology based drug delivery.

QUICK LINK

Inquiry

Sender
/
Purpose *
Available Amount for a deal *
Details

SHARE

SHARE

REQUEST THE VIDEO MEETING

  • (KST, UTC+09:00)

    This above time is Korean local time.
    The time for meeting is based on Korean local time.
    Please check Korean time, and choose the time available.
Sender
/ SOPH Magnetics
Receiver
Ashok Kumar Patra / IMGENEX INDIA PVT LTD
Purpose *
Available Amount for a deal *
Date *
Time *
Attendee 1 *
Attendee 2
Massage